Q&A: Pfizer Researcher on the PSTC and Applying Bradford Hill's Principles to Biomarker Development

ProteoMonitor spoke to Josef Ozer, senior principal scientist at Pfizer, about his work as part of the Predictive Safety Testing Consortium and his recent paper applying Bradford Hill's Principles of Causality Association to biomarker research.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.